The group was founded in 2008 as a collaboration with Massachusetts General Hospital (Boston, MA), the Mayo Clinic (Rochester, MN) and the Memorial Sloan Kettering Cancer Center (New York, NY). This alliance was the first of its kind created to gain insight into rare and difficult-to-treat tumors. Over the past four years, it has evolved to become a truly multidisciplinary forum.
This course consists of didactic lectures with question and discussion periods as well as case presentations.
A course evaluation form via an e-link will provide attendees with the opportunity to review the sessions and the speakers and to identify future educational needs.
This course is directed toward orthopedic surgeons, general surgeons, plastic surgeons, radiation oncologist, pathologists, statisticians and basic scientists, who wish to broaden their understanding of rare and difficult-to-treat sacro pelvic tumors.
Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.